Lubin Named CEO of Oakland Hospital
August 20, 2009 – On August 5, Dr. Bertram Lubin, who as Senior Vice President of Children’s Hospital Oakland Research Institute (CHORI) has championed many important thalassemia-related projects, was named the new Chief Executive Officer (CEO) of Children’s Hospital & Research Center Oakland (CHRCO).
| Is Your Information Up-to-Date? We can’t communicate with you if we have out-of-date information. Please forward updated addresses, emails, phone numbers, etc. to us so we can keep you in the loop. |
Dr. Lubin first joined Children’s Hospital 38 years ago and has since served as the chief of hematology/oncology before his most recent appointment as the Senior Vice President, Research at CHORI. Amongst numerous highlights and accomplishments under Dr. Lubin’s leadership, CHORI developed the nation’s first sibling cord blood program and advanced the medical care and treatment of sickle cell and thalassemia for pediatric patients. As a result, CHORI has become a leading institution in research and currently ranks sixth nationally in National Institutes of Health research awards to children’s hospitals.
Dr. Lubin is the first MD to serve as CEO at CHRCO.
In an article in the San Francisco Business Times, Dr. Lubin said, “I am honored to lead Children’s Hospital Research Center Oakland. There are important challenges ahead, and I look forward to working closely with the medical staff and the communities we serve to deliver the highest quality pediatric care for all children.”
CAF congratulates Dr. Lubin on his appointment to this prestigious position and wishes him well as he leads CHRCO in the years ahead.